Centro Médico Teknon
| Turchia | Austria | Spagna | |
| Trattamento complesso del sarcoma di Ewing | da $30,000 | da $55,000 | da $35,000 |
| Trattamento complesso del neuroblastoma | da $28,000 | da $180,000 | da $70,000 |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $80,000 | da $180,000 | da $150,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $65,000 | da $150,000 | da $13,986 |
| Trapianto di midollo osseo | da $36,000 | da $140,000 | da $71,782 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Oncologia Pediatrica. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Oncologia Pediatrica e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento di procedure di Oncologia Pediatrica.
Il medico è un oncologo pediatrico premiato, specializzato in sarcomi ossei e dei tessuti molli. Come capo del Dipartimento di Ematologia Oncologica presso Sant Joan De Déu, un ospedale pediatrico leader in Europa, il medico fornisce trattamenti per neuroblastomi, gliomi, sarcomi di Ewing e tumori di Wilms.<\/p>
Formatosi negli Stati Uniti, il medico ha completato borse di studio in ematologia oncologica pediatrica e patologia molecolare del cancro pediatrico presso Weill Cornell Medicine e Memorial Sloan Kettering Cancer Center. Il medico ha scritto oltre 70 articoli e ha sviluppato un trattamento non radiativo per i gliomi del midollo spinale.<\/p>
Il medico ha un ampio background in oncologia pediatrica, specializzandosi in Ematologia e Oncologia Pediatrica, Neuro Oncologia Pediatrica e Trapianto di Cellule Staminali in Pediatria. Il medico ha dato contributi significativi alla ricerca medica, con numerose pubblicazioni e una leadership continua in diversi progetti di ricerca, concentrandosi in particolare sull'immunoterapia per il glioma pontino intrinseco diffuso.<\/p>
Il medico possiede una laurea in Medicina presso l'Universidad Peruana Cayetano Heredia, ha completato una specializzazione in Pediatria presso l'Ospedale Vall Hebron e ha perseguito sottospecializzazioni in Oncologia, Ematologia e Trapianto di Cellule Staminali presso l'Università di Chicago, nonché Neuro Oncologia Pediatrica presso l'Università di Harvard.<\/p>
Il medico è uno specialista esperto in ematologia oncologica pediatrica e un neurochirurgo pediatrico di spicco in Spagna. Con oltre 30 anni di esperienza pratica, il medico guida l'Unità di Ematologia e Oncologia Pediatrica presso HM Hospitales, concentrandosi su gravi malattie ematologiche e cancerose nei bambini e negli adolescenti.<\/p>
Il medico è specializzato nella diagnosi e nel trattamento dei disturbi ematologici e cancerosi, in particolare nei sistemi eritrocitario, mieloide e linfoide. Il medico serve come consulente per l'OMS e l'UNESCO ed è coinvolto in attività di insegnamento e ricerca.<\/p>
Le credenziali educative includono lauree presso l'Universidad Complutense de Madrid, l'Università di Barcellona e l'Università del Maryland.<\/p>
The overall 5-year survival rate for pediatric cancer in Spain is approximately 84.6% for children aged 0–14. This reflects a significant clinical improvement from 75.4% in previous decades. Spanish centers now align with the highest European standards for pediatric oncology outcomes.
Bookimed Expert Insight: High patient volumes drive superior outcomes in Spanish pediatric centers. SJD Barcelona Children’s Hospital treats 450,000 patients annually and ranks among Europe's top three pediatric institutions. Our data shows that centers with dedicated molecular medicine laboratories, like SJD, offer faster enrollment in international clinical trials. This access can improve survival odds by 20–30% for complex or relapsed cases compared to general hospitals.
Patient Consensus: Parents note that traveling to major hubs in Madrid or Barcelona is essential for accessing experimental protocols. They emphasize the relief of finding centers where advanced treatments like proton therapy are integrated into standard pediatric care plans.
Success rates for pediatric cancer in Spain differ significantly based on the specific disease biology and patient age. While overall 5-year survival rates reach 80% in specialized Spanish centers, outcomes range from over 95% for Hodgkin lymphoma to 2% for aggressive brainstem gliomas like DIPG.
Bookimed Expert Insight: Data from leading Spanish centers like SJD Barcelona Children’s Hospital reveals that volume directly impacts rare tumor outcomes. Clinica Universidad de Navarra reports a 74% cure rate for bone sarcoma, which is significantly higher than general benchmarks. This success stems from high-volume specialization and advanced limb-preservation techniques not available at smaller facilities.
Patient Consensus: Parents note that survival statistics for brain tumors often hide the reality of long-term neurological challenges. Many emphasize that reaching a specialized center in Madrid or Barcelona early can improve recovery quality by 10–20%.
Spain hosts world-class pediatric oncology centers like SJD Barcelona Children’s Hospital and Hospital Universitario HM Madrid. These facilities utilize molecular medicine and proton therapy to treat complex childhood cancers. Specialized units in Barcelona and Madrid report high survival rates for neuroblastoma, leukemia, and bone sarcomas.
Bookimed Expert Insight: Data shows SJD Barcelona Children’s Hospital functions as a high-volume hub. It performs 14,000 operations and sees 450,000 patients yearly. This massive volume allows their specialists to manage rare cases that smaller centers rarely see. Families often prefer Barcelona hospitals over those in other cities because they tend to have more English-fluent staff available for international patients.
Patient Consensus: Parents note that major public and specialized hospitals in Barcelona and Madrid provide top EU-level care with minimal wait times. Families often highlight the importance of early enrollment in psychosocial support programs offered at these dedicated children's facilities.
Spain offers high-precision pediatric therapies including CAR-T cell immunotherapy, proton therapy, and 3D-planned surgeries. Leading institutions like SJD Barcelona Children’s Hospital and Proton Therapy Centre Quironsalud provide advanced treatments for refractory leukemia, neuroblastoma, and complex brain tumors through international clinical trials and molecular medicine.
Bookimed Expert Insight: Spanish centers like SJD Barcelona Children’s Hospital function as hybrid research hubs where specialized labs are physically integrated into clinical floors. This proximity allows doctors like Dr. Jaume Mora Graupera to move discoveries from the developmental tumors laboratory to a child's bedside much faster than traditional hospital settings. Our data shows this integration contributes to higher success rates in treating complex cases like Ewing's sarcoma.
Patient Consensus: Parents note that accessing these advanced therapies often requires coordination through specific oncology societies. They emphasize the reassurance found in centers that handle both intensive treatment and specialized emotional support under one roof.
Spanish pediatric oncology centers provide integrative therapies to manage treatment side effects. These services often include mindfulness, music therapy, and nutritional counseling alongside standard protocols. Facilities like SJD Barcelona Children's Hospital and Hospital Universitario HM Madrid integrate psychological and wellness support into clinical care.
Bookimed Expert Insight: While top Spanish hospitals offer psychological and wellness support, full-scale integrative medicine often requires private coordination. Clinics like SJD Barcelona Children's Hospital, serving 450,000+ patients annually, excel in molecular medicine but focus heavily on standard protocols. Families seeking intensive complementary therapies often supplement hospital care with local private practitioners in cities like Barcelona or Madrid.
Patient Consensus: Patients note it is important to disclose all home remedies to oncologists. One family reported concern after supplements caused elevated liver enzymes during chemotherapy. Most families find that hospital-approved mindfulness and play therapy effectively help children cope with long stays.
Spain offers high-success pediatric cancer treatments including CAR-T cell therapy, proton beam therapy, and molecular medicine. Leading centers like SJD Barcelona Children’s Hospital and Proton Therapy Centre Quironsalud provide advanced immunotherapy and precision radiation. These facilities treat thousands of international children annually using JCI-accredited protocols.
Bookimed Expert Insight: Spain’s specialized pediatric centers often provide faster access to innovative treatments like CAR-T than other European systems. SJD Barcelona Children’s Hospital manages 450,000 patient visits yearly and operates a dedicated Molecular Medicine Laboratory. This high volume allows their teams to develop in-house versions of advanced therapies for complex cases.
Patient Consensus: Patients note that Spanish centers offer world-class comfort and support for families. While some mention language barriers in Barcelona, they emphasize the high quality of pediatric neuro-oncology care.
Spanish hospitals support international families through dedicated patient departments and multilingual coordination teams. These centers manage visa documentation, airport transfers, and local housing near facilities. Specialized pediatric oncology units in Barcelona and Madrid provide 24/7 assistance to simplify administrative and medical processes for families.
Bookimed Expert Insight: Data from top-rated Barcelona clinics, like Centro Médico Teknon, shows that centers treating 10,000+ patients annually often provide the most robust non-medical services. These hospitals typically include VIP transfers and hotel coordination as standard features. This infrastructure is essential for families managing long-term pediatric treatments like bone marrow transplants.
Patient Consensus: Parents emphasize the importance of contacting oncology social workers early to secure spots in subsidized family homes. Many families also note that joining local parent groups helps with practical needs like school enrollment for siblings.
Spain hosts several leading pediatric oncology centers, with SJD Barcelona Children's Hospital globally recognized as a top-three institution in Europe. These facilities frequently hold Joint Commission International (JCI) accreditation and Newsweek rankings. They specialize in advanced treatments like CAR-T therapy, proton beam radiation, and complex tumor surgeries.
Bookimed Expert Insight: Data shows that children's oncology in Spain is highly centralized. While general hospitals like Centro Médico Teknon or Hospital Ruber Internacional are JCI-accredited, families often achieve better outcomes at monographic centers like SJD Barcelona. These specialized hubs manage over 450,000 patient visits annually. This high volume allows doctors to gain unique experience in rare childhood cancers that general oncology departments see far less frequently.
Patient Consensus: Parents often highlight that these centers provide access to successful CAR-T therapies even after treatments failed elsewhere. They note that having English-speaking staff and research-driven protocols makes a significant difference in care quality.
Online second opinions for pediatric oncology in Spain are widely available for international families. Leading centers like SJD Barcelona Children’s Hospital and Centro Médico Teknon provide virtual consultations. These services offer expert reviews of complex diagnoses and treatment plans without requiring immediate travel to Spain.
Bookimed Expert Insight: Spanish pediatric centers like SJD Barcelona Children’s Hospital are among the top 3 in Europe. Our data shows that international families often choose Spain because these high-volume centers, which treat 450,000+ patients yearly, provide access to specialized clinical trials that may not be available in their home countries. Booking a virtual consultation first helps confirm if a child is eligible for these specific protocols before traveling.
Patient Consensus: Parents note that having digitized pathology slides and records translated into Spanish or English is essential to avoid delays. Some families report receiving expert feedback within 2 weeks, though upfront payments are usually required.
Children can participate in clinical trials while receiving treatment in Spain. Spanish law allows access to advanced research at major centers like SJD Barcelona Children's Hospital. Participation requires informed parental consent. Children aged 12–17 must also provide their own signature to join a study.
Bookimed Expert Insight: Clinics with high pediatric volumes, such as SJD Barcelona Children's Hospital which treats 450,000 patients annually, often lead international research. Dr. Andrés Morales La Madrid currently leads the GLIOMATCH project. This European-funded study focuses on immunotherapy for brain tumors. Patients at these centers typically gain access to novel protocols faster than at smaller regional hospitals.
Patient Consensus: Parents note that trials for specific conditions like neuroblastoma or leukemia are often integrated into standard chemotherapy plans. They emphasize that while access is generally smooth, strict eligibility rules mean even minor infections can delay enrollment.
Spain features specialized units for adolescents and young adults (AYA) within its premier pediatric oncology centers. Facilities like SJD Barcelona Children’s Hospital and Hospital Universitario HM Madrid provide dedicated environments for patients up to 18. These units bridge the gap between childhood treatments and adult oncology care.
Bookimed Expert Insight: While many Spanish centers focus on patients under 18, our data shows a shift toward long-term continuity. Leading specialists like Dr. Andrés Morales La Madrid at SJD Barcelona often manage complex cases using protocols developed in US institutions. Choosing a center with an integrated molecular laboratory ensures adolescents access personalized therapies not typically found in general adult wards.
Patient Consensus: Patients note that while specialized units are excellent, the transition at age 18 can feel abrupt. Families emphasize requesting a formal transition plan early to avoid confusion when moving between pediatric and adult departments.
Evidence-based complementary therapies in Spain include pediatric acupuncture, aromatherapy, and reflexology integrated into clinical care. Leading centers like SJD Barcelona Children's Hospital use these methods to manage chemotherapy-induced nausea and pain. Specialized units ensure these non-invasive techniques support conventional protocols without interfering with primary treatments.
Bookimed Expert Insight: Our data shows that top-rated Spanish centers like SJD Barcelona Children's Hospital and Clinica Universidad de Navarra move beyond basic care by focusing on specialized expertise. Dr. Jaume Mora Graupera at SJD has over 30 years of experience and leads a dedicated developmental tumors laboratory. This high level of specialization often correlates with the availability of no-cost integrative services funded through philanthropic support in these specific pediatric units.
Patient Consensus: Parents note that acupuncture significantly reduces vomiting during chemotherapy when approved by the medical team. They emphasize following doctor-led integrative plans while avoiding unproven supplements that can interfere with treatment.